Magnesium 150 mg with Melatonin 3 mg
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Malate de magnésium | 150 mg | 150,000 µg |
| Magnésium Source : Oxyde de magnésium | 150 mg | 150,000 µg |
| Magnésium Source : Succinate de magnésium | 150 mg | 150,000 µg |
| Magnésium Source : Citrate de magnésium | 150 mg | 150,000 µg |
| Magnésium Source : Fumarate de magnésium | 150 mg | 150,000 µg |
| N-Acétyl-5-méthoxytryptamine Source : Mélatonine | 3 mg | Not calculated |
Non-medicinal ingredients
Croscarmellose de sodium, Amidon de maïs, Dioxyde de titane, Poly(alcool vinylique), Poly(éthylène glycol), Carbonate de calcium, Cellulose microcristalline, Talc, Hypromellose, Povidone, Poly(dextrose), Dioxyde de silicium, Carboxyméthylcellulose de sodium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Used as a) sleep aid (to help promote sleep). Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps (to) prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones). Helps (to) speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Helps (to) re-set the body's sleep-wake cycle (aspect of the circadian rhythm). A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in bone development. Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps to maintain/support heart muscle function. Helps to maintain/support normal electrolyte balance. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support normal muscle function. Helps to maintain/support the body's ability to metabolize nutrients. Maintains/supports good health. Mineral supplement. Source of/Provides (an) electrolyte(s) for the maintenance of good health. Source of/Provides (an) electrolyte(s). Source of mineral to support biological functions which play a key role in the maintenance of good health. Source of mineral, a factor in normal growth and development. Source of mineral, a factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Magnesium + Melatonin, Magnesium 150 mg Plus Melatonin 3 mg, Magnesium Plus Melatonin, Magnesium with Melatonin
- Licence holder
- Vita Health Products Inc.
- NPN or DIN-HM
- 80127664
- Status
- Active licence
- Licence date
- 31 October 2023
- Revision date
- 31 July 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80127664
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Magnesium 150 mg with Melatonin 3 mg”, https://compoatlas.com/en/supplements/canada/80127664-magnesium-150-mg-with-melatonin-3-mg, updated 31 July 2025.